CERUBIDINE (DAUNORUBICIN HYDROCHLORIDE) — FDA Approval ANDA061876 (SANOFI AVENTIS US)
CERUBIDINE (DAUNORUBICIN HYDROCHLORIDE) — FDA Approval ANDA061876 (SANOFI AVENTIS US) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CERUBIDINE; Active ingredients: DAUNORUBICIN HYDROCHLORIDE; Application number: ANDA061876.
| Brand name | CERUBIDINE |
|---|---|
| Active ingredients | DAUNORUBICIN HYDROCHLORIDE |
| Application number | ANDA061876 |
| Sponsor | SANOFI AVENTIS US |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19800205 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →